Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Cryo-Cell International, Inc. - Common Stock (NY:CCEL)

3.370 -0.250 (-6.91%)
Official Closing Price Updated: 8:00 PM EDT, May 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cryo-Cell International, Inc. - Common Stock

News headline image
Cryo-Cell Receives Acceptance of Compliance Plan From NYSE American
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cryo-Cell Receives NYSE American Continued Listing Notice
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cryo-Cell International, Inc. Provides Dividend Update
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
News headline image
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.